Cancer Letters
Volume 243, Issue 2 , Pages 211-216 , 18 November 2006

MK-1 expression in carcinoma of the ampulla of Vater as a predictor of improved prognosis after surgical resection

  • Yoshihiro Hamada

      Affiliations

    • Department of Pathology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 92 801 1011; fax: +81 92 861 7300.
    • ,
  • Yoshifuku Nakayama

      Affiliations

    • Department of Pathology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
    • ,
  • Mikiro Mizoguchi

      Affiliations

    • Department of Pathology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
    • ,
  • Seiyo Ikeda

      Affiliations

    • 1st Department of Surgery, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
    • ,
  • Masahide Kuroki

      Affiliations

    • Department of Biochemistry, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
    • ,
  • Hiroshi Iwasaki

      Affiliations

    • Department of Pathology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

Received 2 August 2005 ,Revised 28 October 2005 ,Accepted 27 November 2005.

References 

  1. Albores-Saavedra J, Henson DE, Klimstra DS. Atlas of tumor pathology,. Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater, Third series. Washington, DC: Armed Forces Institute of Pathology; 1998;
  2. Neoptolemus JP, Talbot IC, Carr-Locke DL, Shaw DE, Cockleburgh R, Hall AW, et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br. J. Surg. 1987;74:957–961
  3. Robertson JF, Imrie CW, Hole DJ, Carter DC, Blumgart LH. Management of periampullary carcinoma. Br. J. Surg. 1987;74:816–819
  4. Allema JH, Reinders ME, van Gulik TM, van Leeuwen DJ, Verbeek PC, de Wit LT, et al. Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival. Surgery. 1995;117:247–253
  5. Watanabe R, Johzaki H, Iwasaki H, Kikuchi M, Ikeda S. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma. Cancer. 1993;71:2439–2447
  6. Arakawa F, Yamamoto T, Kanda H, Watanabe T, Kuroki M. cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse/human chimeric antibody. Hybridoma. 1999;18:131–138
  7. Winter MJ, Nagtegaal ID, van Krieken JHJM, Litvinov SV. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am. J. Pathol. 2003;163:2139–2148
  8. Albores-Saavedra J, Scoazec JC, Wittekind C, Spira B. Histological Classification of the Gallbladder and Extrahepatic Bile Ducts. Geneva, Switzerland: World Health Organization; 1999;pp. 203–218
  9. Japanese Society of Biliary Surgery, Classification of Biliary Tract Carcinoma, First English Edition, Kanehara & Co. Ltd, Tokyo, 2001.
  10. Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the ampulla of vater: experience with local or radical resection in 171 consecutively treated patients. Arch. Surg. 1999;134:526–532
  11. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery. 1997;121:611–617
  12. Klempnauer J, Ridder GJ, Maschek H, Pichlmayr R. Carcinoma of the ampulla of Vater: determinants of long-term survival in 94 resected patients. HPB Surg. 1998;11:1–11
  13. Monson RT, Honohue JH, McEntee GP, McIlrath DC, van Heerden JA, Shorter RG, et al. Radical resection for carcinoma of the ampulla of vater. Arch. Surg. 1991;126:353–357
  14. Talbot IC, Neoptolemos JP, Shaw DE, Carr-Locke D. The histopathology and staging of carcinoma of the ampulla of vater. Histopathology. 1988;12:155–165
  15. Litvinov SV. Ep-CAM: a homophilic cell–cell adhesion molecule with EGF-like domains. Trends Glycosci. Glycotechnol. 1995;7:375–384
  16. Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS, et al. Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J. Natl Cancer Inst. 1998;90:691–697
  17. Tandon AK, Clark GM, Chamnes GC, McGuire WL. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res. 1990;50:3317–3321
  18. Songun I, Litvinov SV, van de Velde CJH, Pals ST, Hermans J, van Krieken JHJM. Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br. J. Cancer. 2005;92:1767–1772
  19. Joo M, Kim H, Kim MK, Yu HJ, Kim JP. Expression of Ep-CAM in gastric in intestinal metaplasia, gastric epithelial dysplasia, and ggastric adenocarcinoma. J. Gastroenterol. Hepatol. 2005;20:1039–1045
  20. Litvinov SV, vans Driel W, van Rhijin CM, Bakker HA, van Krieken H, Fleuren GJ, et al. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am. J. Pathol. 1996;148:865–875
  21. Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC, Grizzle WE. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum. Pathol. 2000;31:482–487
  22. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, et al. Adenocarcinoma of the ampulla of vater. A 28-year experience. Ann. Surg. 1997;225:590–600
  23. Farrell RJ, Noonan N, Khan IM, Goggins M, Kelleher DP, Keeling PW. Carcinoma of the ampulla of vater: a tumour with a poor prognosis?. Eur. J. Gastroenterol. Hepatol. 1996;8:139–144
  24. Kimura W, Futakawa N, Yamagata S, Wada Y, Kuroda A, Muto T, et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of vater. Jpn. J. Cancer Res. 1994;85:161–166
  25. Verga M, Obrist P, Schneeberger S, Muhlmann G, Felgel-Farnholz C, Fong D, et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor suvival. Clin. Cancer Res. 2004;10:3131–3136
  26. Gastl G, Spizzo G, Obrist P, Dünser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet. 2000;356:1981–1982

PII: S0304-3835(05)01042-6

doi: 10.1016/j.canlet.2005.11.037

Cancer Letters
Volume 243, Issue 2 , Pages 211-216 , 18 November 2006

Article Tools

* Image Usage & Resolution